Physician profile
Marisa L Mosier
NPI 1114508686
$10,004.68
in general payments reported to CMS, 2019-2025
14 companies · $4,200 in 2025
The $4,200 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $127 · 2024: $5,678 · 2025: $4,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,694 · Food and Beverage: $3,178 · Entertainment: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,694.45 |
| Food and Beverage | $3,178.08 |
| Entertainment | $132.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,563.77 | 2024-2025 | Citrefix, Ortholoc 3di, Salvation |
| Orthofix Medical, INC. | $3,534.52 | 2024 | Truelok |
| Fortis Surgical, LLC | $457.17 | 2024-2025 | |
| Medtronic, INC. | $373.08 | 2024-2025 | Intellis Adaptivestim, Venaseal |
| Arthrex, INC. | $288.20 | 2025 | |
| Polynovo North America LLC | $172.97 | 2024 | Novosorb Btm |
| Kerecis Limited | $152.88 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Nuo Therapeutics | $132.15 | 2025 | |
| Anika Therapeutics, INC. | $126.78 | 2023 | Tactoset, Toemotion, X-Twist |
| Paratek Pharmaceuticals, INC. | $121.73 | 2024 | Nuzyra |
| Smith+Nephew, INC. | $24.48 | 2025 | Stravix Pl |
| Bioventus LLC | $22.74 | 2025 | Exogen Ultrasound Bone Healing System |
| Innovation Technologies INC | $17.38 | 2025 | Irrisept |
| Flower Orthopedics Coporation | $16.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Mosier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.